| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |